India-first, global-first formulations.
Biodeal's DSIR-approved R&D centre turns molecules into regulated-market products — designing the formulation, the device and the dossier in-house, from first prototype to commercial launch.
The science behind a metered dose.
Intranasal delivery is a precision-engineering problem as much as a formulation one. We characterise plume geometry, particle-size distribution and spray pattern against validated specs — then match the pump architecture to the dose.
Midazolam Nasal Spray · 1.25% w/v · metered-doseFrom molecule to metered device.
Metered-dose, aqueous, saline, antihistamine, corticosteroid and nicotine BP formats — formulated, filled and sealed in-house under WHO-GMP, with pump selection and fill-volume specified at the R&D stage.
Full nasal spray CDMODry powder inhalers, device and capsule.
Beyond nasal, Biodeal extends its respiratory-delivery depth into dry powder inhalation — both the DPI device and the DPI capsule manufacturing that feeds it — for fine-particle pulmonary delivery without propellants.
DPI device
Breath-actuated capsule inhalers engineered for consistent fine-particle dose to the lung.
DPI capsule
In-house capsule filling and capability — the metered powder payload the device pierces and delivers.
A working pipeline, not a brochure promise.
Biodeal's DSIR-approved development centre runs a live portfolio — staffed by formulation & development resources and qualified scientists, weighted toward regulated and first-in-market filings.
A combined bench of 14 formulation & development resources and 11 qualified scientists working concept-to-commercial, in-house.
A government-recognised R&D centre — formulation design, ICH stability studies and CTD/ACTD dossier preparation, concept to commercial.
Live development projects in flight across dosage forms and markets.
Projects targeting US-market registration and the most demanding regulators.
India-first vs global-first.
Of the seven active projects, the split is weighted toward products developed for the world market before — or alongside — India.
From a validated molecule to a registered product.
A single, accountable development partner — covering formulation design, the studies regulators demand, and the dossier that gets your product to market.
Methods that hold up to any pharmacopoeia.
A modern QC backbone underwrites every formulation — validated analytical methods, multi-pharmacopoeia compliance and stability data generated to the standard the next market will ask for.
ICH stability chambers
Accelerated and long-term studies across the four ICH climatic zones, generating the shelf-life data regulators require.
Validated QC methods
HPLC, GC and dissolution instrumentation with validated methods and in-process plus finished-product release testing.
Multi-pharmacopoeia
Testing to IP, BP, USP and other monograph standards — so a single development effort can clear multiple markets.
Tell us what you need to make.
A focused brief gets you a routed answer from the right team within one working day.